Lyme disease is one of the fastest spreading conditions in North America and scientists are constantly working on new treatments and detection procedures. One of the main problems surrounding Lyme disease it that it can be difficult to detect with the current blood test procedure recommended by the Centers for Disease Control and Prevention. This is because the Borrelia burgdorferi bacteria that causes the condition can take weeks or even months to develop to a visible level.
Early detection of Lyme disease is key in the successful treatment of this condition, so scientists are keen to implement a more effective test procedure. Lyme disease is transmitted to humans and animals by the bites of infected blacklegged ticks. This disease can cause a number of symptoms from fatigue and nausea through to more serious rheumatological, neurological and cardiac complications.
Lyme Symptoms
Lyme disease can be difficult to diagnose on testing alone so it is important that both patients and doctors understand symptoms. If you have been exposed to ticks and start to feel unwell you should visit your healthcare advisor as soon as possible. Symptoms can include feelings of tiredness, nausea, muscle weakness and constant headaches. You should also look out for the characteristic ‘bulls eye’ rash which often appears in conjunction with Lyme disease. This rash can appear anywhere between three days to four weeks after the initial infection. Commonly the rash manifests initially around the original infection site. Lyme disease can remain dormant in the body for some time before any symptoms start to show. This means that the patient may not remember having been exposed to ticks. This is why it is so important that healthcare advisors have access to an accurate method of testing to identify this disease for treatment.
Luciferase Immunoprecipitation System (LIPS)
The luciferase immunoprecipitation system (LIPS) test has been around for a few years now and has been used to detect a number of viral and fungal pathogens that can affect the body. Researchers at the National Institutes of Health have recently announced successful results in the using the LIPS test for Lyme disease. These results were reported in the recent June 2010 edition of the respected journal ‘Clinical and Vaccine Immunology’.
In the latest research from the National Institutes of Health the LIPS test was evaluated for its effective at detecting antibody responses to Lyme bacteria. Blood tests were taken from infected patients and also those that had not been exposed to Lyme disease. Researchers found that 98 to 100% of patients were correctly diagnosed as having Lyme disease through using the LIPS test in combination with the synthetic protein VOVO. The report suggested that :
‘…screening by the LIPS test with VOVO and other B. burgdorferi antigens offers an efficient quantitative approach for evaluation of the antibody responses in patients with Lyme disease.’
These results are very impressive and the rollout of screening for Lyme disease through LIPS test with VOVO could offer an effective way to diagnose Lyme Disease quickly and effectively in the future.











